These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 854722)

  • 1. [Does cholestyramine impair the bioavailability of prednisolone?].
    Audétat V; Paumgartner G; Bircher J
    Schweiz Med Wochenschr; 1977 Apr; 107(15):527-8. PubMed ID: 854722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics.
    Malloy MJ; Ravis WR; Pennell AT; Hagan DR; Betagari S; Doshi DH
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):286-9. PubMed ID: 7921528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.
    Hunninghake DB; King S; LaCroix K
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):151-4. PubMed ID: 7076343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholestyramine resin on single dose valproate pharmacokinetics.
    Malloy MJ; Ravis WR; Pennell AT; Diskin CJ
    Int J Clin Pharmacol Ther; 1996 May; 34(5):208-11. PubMed ID: 8738857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of prednisolone during simultaneous treatment with cholestyramine.
    Audetat V; Bircher J
    Gastroenterology; 1976 Dec; 71(6):1110-1. PubMed ID: 992273
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of cholestyramine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of cholestyramine on phenytoin bioavailability.
    Barzaghi N; Monteleone M; Amione C; Lecchini S; Perucca E; Frigo GM
    J Clin Pharmacol; 1988 Dec; 28(12):1112-4. PubMed ID: 3243928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of cholestyramine and chloroquine].
    Gendrel D; Verdier F; Richard-Lenoble D; Nardou M
    Arch Fr Pediatr; 1990 May; 47(5):387-8. PubMed ID: 2369274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sodium taurocholate, cholestyramine, and mylanta on the intestinal absorption of glucocorticoids in the rat.
    Ware AJ; Combes B
    Gastroenterology; 1973 Jun; 64(6):1150-5. PubMed ID: 4706135
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cholestyramine on vitamin E levels in patients treated with statins.
    Kersting F; Selenka A; Walch S
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1476-9. PubMed ID: 11185669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of folate following ingestion of cholestyramine in the rat.
    Hoppner K; Lampi B
    Int J Vitam Nutr Res; 1991; 61(2):130-4. PubMed ID: 1917349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and carbohydrate metabolism in cholestyramine-fed rats.
    Meijer GW; Beynen AC
    Artery; 1989; 16(5):286-92. PubMed ID: 2764732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral anticoagulant therapy with special reference to the influence of food and drug interactions].
    Aosaki M
    Kokyu To Junkan; 1991 Aug; 39(8):779-88. PubMed ID: 1681576
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cholestyramine and chenodesoxycholic acid on liver cirrhosis. An experimental study in rats].
    de Heer K; Werner B; Sauer HD; Klöppel G
    Z Exp Chir; 1980 Apr; 13(2):105-13. PubMed ID: 7445625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable interaction of loperamide and cholestyramine.
    Ti TY; Giles HG; Sellers EM
    Can Med Assoc J; 1978 Sep; 119(6):607-8. PubMed ID: 709452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.